| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2097938-44-6 | Pomalidomide-PEG4-C-COOH |
| | 询价 |
| 2 | | Pomalidomide-PEG3-C2-NH2(TFA) |
| 100mg | 询价 |
| 3 | 2305369-00-8 | Pomalidomide-C2-NH2 hydrochloride |
| | 询价 |
| 4 | 2098836-50-9 | AT6 |
| | 询价 |
| 5 | 1835705-59-3 | (S,R,S)-AHPC-PEG6-C4-Cl(VH032-PEG6-C4-Cl) |
| | 询价 |
| 6 | 2064292-52-8 | (S,R,S)-AHPC-PEG4-NH2 hydrochloride(VH032-PEG4-NH2 hydrochloride) |
| | 询价 |
| 7 | 2010159-57-4 | (S,R,S)-AHPC-PEG4-NH2(VH032-PEG4-NH2) |
| | 询价 |
| 8 | 1797406-81-5 | (S,R,S)-AHPC-PEG4-N3(VH032-PEG4-N3) |
| | 询价 |
| 9 | 2097971-11-2 | (S,R,S)-AHPC-PEG3-NH2 hydrochloride(VH032-PEG3-NH2 hydrochloride) |
| | 询价 |
| 10 | 1797406-80-4 | (S,R,S)-AHPC-PEG3-N3(VH032-PEG3-N3) |
| | 询价 |
| 11 | 2097973-72-1 | (S,R,S)-AHPC-PEG2-NH2 hydrochloride(VH032-PEG2-NH2 hydrochloride) |
| | 询价 |
| 12 | 2010159-45-0 | (S,R,S)-AHPC-PEG2-N3(VH032-PEG2-N3) |
| | 询价 |
| 13 | 1835705-57-1 | (S,R,S)-AHPC-PEG2-C4-Cl(VH032-PEG2-C4-Cl) |
| | 询价 |
| 14 | 2101200-09-1 | (S,R,S)-AHPC-PEG1-N3(VH032-PEG1-N3) |
| | 询价 |
| 15 | 1948273-03-7 | (S,R,S)-AHPC-Me hydrochloride |
| | 询价 |
| 16 | 2138861-99-9 | ABBV-744 |
| | 询价 |
| 17 | | (S,R,S)-AHPC-Me dihydrochloride |
| | 询价 |
| 18 | 1835705-55-9 | (S,R,S)-AHPC-C6-PEG3-C4-Cl(VH032-C6-PEG3-C4-Cl) |
| | 询价 |
| 19 | 2245697-83-8 | (S,R,S)-AHPC-C3-NH2(VH032-C3-NH2) |
| | 询价 |
| 20 | 1835705-61-7 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
| | 询价 |
| 21 | 1448189-80-7 | (S,R,S)-AHPC hydrochloride(MDK7526 hydrochlorideVH032-NH2 hydrochloride) |
| | 询价 |
| 22 | 13408-09-8 | β-Glycerol phosphate disodium salt pentahydrate [CAS 13408-09-8] |
| | 询价 |
| 23 | 476310-60-8 | VO-Ohpic trihydrate(VO-Ohpic) |
| | 询价 |
| 24 | 844499-71-4 | A-769662 |
| | 询价 |
| 25 | 345630-40-2 | SF1670(PTPase CD45 Inhibitor) |
| | 询价 |
| 26 | 371942-69-7 | YM-201636 |
| | 询价 |
| 27 | 900874-91-1 | T-00127_HEV1 |
| | 询价 |
| 28 | 593960-11-3 | PIK-93 |
| | 询价 |
| 29 | 1429624-84-9 | PI4KIIIbeta inhibitor 9 |
| | 询价 |
| 30 | 1245319-54-3 | PI4KIII beta inhibitor 3 |
| | 询价 |
| 31 | 1610610-48-4 | KDU731 |
| | 询价 |
| 32 | 1889279-16-6 | A-485 |
| | 询价 |
| 33 | 1527503-11-2 | A-366 |
| | 询价 |
| 34 | 1433286-70-4 | 666-15 |
| | 询价 |
| 35 | 1621-56-3 | 7-Methoxyisoflavone |
| 100mg | 询价 |
| 36 | 5189-11-7 | Pizotifen Malate |
| 100mg, 200mg | 询价 |
| 37 | 72496-41-4 | Pirarubicin |
| 10mg, 50mg, 100mg | 询价 |
| 38 | 28721-07-5 | Oxcarbazepine |
| 10mg, 50mg | 询价 |
| 39 | 838-07-3 | 5-Methyl-2'-deoxycytidine |
| 100mg | 询价 |
| 40 | 120964-45-6 | 3-Deazaneplanocin A hydrochloride(DZNep HClNSC 617989 HCl3-Deazaneplanocin HCl) |
| | 询价 |
| 41 | 102052-95-9 | 3-Deazaneplanocin A(NSC 6179893-DeazaneplanocinDZNep) |
| | 询价 |
| 42 | 1349719-98-7 | (S)-JQ-35(TEN-010) |
| | 询价 |
| 43 | 1268524-71-5 | (R)-(-)-JQ1 Enantiomer |
| | 询价 |
| 44 | 1092578-47-6 | (3S,4S)-Tofacitinib |
| | 询价 |
| 45 | 1092578-48-7 | (3S,4R)-Tofacitinib |
| | 询价 |
| 46 | 1092578-46-5 | (3R,4S)-Tofacitinib |
| 5mg | 询价 |
| 47 | 90365-57-4 | (-)-Indolactam V(Indolactam V) |
| 5mg | 询价 |
| 48 | 2115701-93-2 | (+)-JQ1 PA |
| | 询价 |
| 49 | 1268524-70-4 | (+)-JQ-1(JQ1) |
| | 询价 |
| 50 | 873697-71-3 | Omecamtiv mecarbil(CK-1827452) |
| | 询价 |
| 51 | 224579-74-2 | MLCK inhibitor peptide 18 |
| | 询价 |
| 52 | 110448-33-4 | ML-7 hydrochloride |
| | 询价 |
| 53 | 1642288-47-8 | Mavacamten(MYK461SAR439152) |
| | 询价 |
| 54 | 84468-24-6 | HA-100 |
| | 询价 |
| 55 | 114977-28-5 | Docetaxel(RP-56976) |
| | 询价 |
| 56 | 796073-69-3 | DM4 |
| | 询价 |
| 57 | 74588-78-6 | D-64131 |
| | 询价 |
| 58 | 1000852-17-4 | Crolibulin(EPC2407) |
| | 询价 |
| 59 | 2070009-55-9 | PF-2771 |
| | 询价 |
| 60 | 1025967-78-5 | Lifitegrast(SAR 1118) |
| | 询价 |
m.cnreagent.com